|
2023
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of mitochondrial diseases and disord... |
|
|
Invention
|
Use of ppar-delta agonists in the treatment of disease.
Described herein is the use sodium (E)-2... |
|
|
Invention
|
Crystalline ppar-delta agonist.
Described herein is crystalline sodium (E)-2-(4-((3-(4-fluorophe... |
|
|
Invention
|
Use of ppar-delta agonists in the treatment of disease. Described herein is the use sodium (E)-2-... |
|
2022
|
Invention
|
Crystalline pparδ agonist. Described herein is crystalline sodium (E)-2-(4-((3-(4-fluorophenyl)-3... |
|
2021
|
Invention
|
Methods of making a ppar-delta agonist.
Described herein are methods of making the PPARδ agonist... |
|
|
Invention
|
Methods of making a ppar-delta agonist. Described herein are methods of making the PPAR? agonist ... |
|
|
Invention
|
Methods of making a ppar-delta agonist. Described herein are methods of making the PPARδ agonist ... |
|
|
Invention
|
Crystalline ppar-delta agonist. Described herein is crystalline sodium (E)-2-(4-((3-(4-fluorophen... |
|
2020
|
Invention
|
Using of a ppar-delta agonist in the treatment of kidney disease.
Described herein is the use of... |
|
|
Invention
|
Use of a ppar-delta agonist in the treatment of kidney disease. Described herein is the use of a ... |
|
|
Invention
|
Use of ppar-delta agonists in the treatment of mitochondrial myopathy.
Described herein is the u... |
|
|
Invention
|
Use of ppar-delta agonists in the treatment of mitochondrial myopathy. Described herein is the us... |
|
|
Invention
|
Use of a ppar-delta agonist in the treatment of fatty acid oxidation disorders (faod).
Described... |
|
|
Invention
|
Use of a ppar-delta agonist in the treatment of fatty acid oxidation disorders (faod). Described ... |
|
2018
|
G/S
|
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal prep... |
|
|
G/S
|
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals, namely antibacterial gels, a... |
